HK Stock MarketDetailed Quotes

01099 SINOPHARM

Watchlist
  • 21.500
  • +0.750+3.61%
Market Closed May 10 16:08 CST
67.09BMarket Cap6.85P/E (TTM)

SINOPHARM Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SINOPHARM Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 26, 2024

Revenue(YoY)

147.27B

+1.20%
EPS(YoY)

0.47

-8.01%
Analyst Rating

Strong Buy

May 12, 2024

SINOPHARM Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Mar 22, 20242023/Q4150.650B / 150.446B--
Oct 27, 20232023/Q3144.969B / 152.155B--
Aug 25, 20232023/Q2155.433B / 144.735B--
Apr 27, 20232023/Q118.687B / ----
DatePeriodRevenue/EstimateEarnings Call
Mar 22, 20242023/Q4150.650B / 150.446B--
Oct 27, 20232023/Q3144.969B / 152.155B--
Aug 25, 20232023/Q2155.433B / 144.735B--
Apr 27, 20232023/Q118.687B / ----

SINOPHARM Earnings Reports

  • SINOPHARM: ANNOUNCEMENT QUARTERLY FINANCIAL INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2024

    Apr 29 08:00

  • SINOPHARM: Annual Report 2023

    Apr 26 16:30

  • SINOPHARM: ANNOUNCEMENT PRINCIPAL UNAUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM (CNCM LTD) FOR THE FIRST QUARTER ENDED 31 MARCH 2024

    Apr 25 21:17

  • SINOPHARM: ANNOUNCEMENT PRINCIPAL UNAUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM ACCORD FOR THE FIRST QUARTER ENDED 31 MARCH 2024

    Apr 25 18:00

    • Read more

    Analysis

    Analyst Rating

    Updated: May 12, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    %Chg